Literature DB >> 14751456

Reduced 5-HT3 receptor binding and lower baseline plus maze anxiety in the alcohol-preferring inbred fawn-hooded rat.

Julie G Hensler1, Clyde W Hodge, David H Overstreet.   

Abstract

The present investigation sought to explore the relationship between the 5-HT(3) receptor and anxiety-like behavior in fawn-hooded (FH/Wjd) rats, an inbred strain that exhibits a high intake and preference for ethanol, and the alcohol-nonpreferring ACI/N strain. Using quantitative autoradiography, we examined whether there were differences in central 5-HT(3) receptor binding in FH/Wjd versus ACI/N rats. Ten to 14 days prior to being used in the autoradiographic studies, rats were first confirmed to be representative of their strains by subjecting them to a two-bottle choice procedure for 2 weeks. The binding of [3H]LY 278584 to 5-HT(3) receptors was significantly reduced in frontal cortex, CA1 region of hippocampus, and in the medial and lateral nuclei of the amygdala of FH/Wjd versus ACI/N rats. In the anterior cingulate cortex and in the dentate gyrus region of the hippocampus the reduction in [3H]LY 278548 binding in the FH/Wjd versus ACI/N strain (40% and 41%, respectively) did not reach statistical significance. In a separate group of animals, the effects of the 5-HT(3) receptor antagonist MDL 72222 (3 mg/kg ip) on anxiety-related behaviors were assessed in the elevated plus maze. In vehicle-treated rats, the FH/Wjd strain exhibited significantly greater percent of time spent on the open arms and percent open arm entries, an indication of less anxiety. Pretreatment with MDL 72222 did not alter these behaviors in the FH/Wjd rats, but had an anxiolytic-like effect in the ACI/N strain, significantly increasing the percent of time spent on the open arms and percent open arm entries. Further research into 5-HT(3) receptor function in the alcohol-preferring FH/Wjd rats is needed to elucidate the relationship among 5-HT(3) receptors, alcohol drinking, and anxiety.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14751456     DOI: 10.1016/j.pbb.2003.11.015

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  7 in total

1.  Corticotropin-releasing factor 1 antagonists selectively reduce ethanol self-administration in ethanol-dependent rats.

Authors:  Cindy K Funk; Eric P Zorrilla; Mei-Jing Lee; Kenner C Rice; George F Koob
Journal:  Biol Psychiatry       Date:  2006-07-28       Impact factor: 13.382

2.  Effects of voluntary ethanol consumption on emotional state and stress responsiveness in socially isolated rats.

Authors:  Maria Giuseppina Pisu; Maria Cristina Mostallino; Riccardo Dore; Elisabetta Maciocco; Pietro Paolo Secci; Mariangela Serra
Journal:  Eur Neuropsychopharmacol       Date:  2010-11-10       Impact factor: 4.600

3.  Repeated Forced Swim Exacerbates Methamphetamine-Induced Neurotoxicity: Neuroprotective Effects of Nanowired Delivery of 5-HT3-Receptor Antagonist Ondansetron.

Authors:  José Vicente Lafuente; Aruna Sharma; Dafin F Muresanu; Asya Ozkizilcik; Z Ryan Tian; Ranjana Patnaik; Hari S Sharma
Journal:  Mol Neurobiol       Date:  2018-01       Impact factor: 5.590

Review 4.  The role of 5-HT3 receptors in drug abuse and as a target for pharmacotherapy.

Authors:  E A Engleman; Z A Rodd; R L Bell; J M Murphy
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-11       Impact factor: 4.388

5.  Bleeding Diathesis in Fawn Hooded Rats-Possible Implications for Invasive Procedures and Refinement Strategies.

Authors:  Manon W H Schaap; Hugo van Oostrom; Saskia S Arndt; Ludo J Hellebrekers
Journal:  Animals (Basel)       Date:  2015-04-24       Impact factor: 2.752

Review 6.  Advances in Medications and Tailoring Treatment for Alcohol Use Disorder.

Authors:  Chamindi Seneviratne; Bankole A Johnson
Journal:  Alcohol Res       Date:  2015

Review 7.  Serotonergic Neuroplasticity in Alcohol Addiction.

Authors:  Arnauld Belmer; Omkar L Patkar; Kim M Pitman; Selena E Bartlett
Journal:  Brain Plast       Date:  2016-06-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.